Duspatalin and Fatigue - a phase IV clinical study of FDA data

Summary:

Fatigue is reported as a side effect among people who take Duspatalin (mebeverine hydrochloride), especially for people who are female, 60+ old, also take Tasigna, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Fatigue when taking Duspatalin. It is created by eHealthMe based on reports of 333 people who have side effects when taking Duspatalin from the FDA, and is updated regularly.

What is Duspatalin?

Duspatalin has active ingredients of mebeverine hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 363 Duspatalin users. Check the latest studies of Duspatalin.

What is Fatigue?

Fatigue (feeling of tiredness) is found to be associated with 4,027 drugs and 6,379 conditions by eHealthMe. Check the latest studies of Fatigue.

On Jul, 08, 2026

333 people reported to have side effects when taking Duspatalin.
Among them, 13 people (3.9%) have Fatigue.

Among these 13 people:

What is the gender of people who have Fatigue when taking Duspatalin? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Fatigue when taking Duspatalin? *

What are other drugs people take besides Duspatalin? *

What are other side effects people have besides Fatigue? *

Diarrhea: 6 people, 46.15%
Peripheral Swelling: 5 people, 38.46%
Back Pain: 5 people, 38.46%
Headache (pain in head): 5 people, 38.46%
Abdominal Pain: 4 people, 30.77%
Pain: 4 people, 30.77%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 30.77%
Joint Pain: 4 people, 30.77%
High Blood Pressure: 4 people, 30.77%
Pain In Extremity: 4 people, 30.77%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 30.77%
Thyroid Diseases: 3 people, 23.08%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 3 people, 23.08%
Sleep Disorder: 2 people, 15.38%
Dry Eyes (lack of adequate tears): 2 people, 15.38%
Gastritis (inflammation of stomach): 2 people, 15.38%
Abdominal Pain: 2 people, 15.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
Pain: 2 people, 15.38%
Myosclerosis (hardening of muscle tissue): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Duspatalin and have Fatigue?

- Check whether Fatigue is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duspatalin:

Duspatalin (363 reports)

Fatigue treatments and more:

Fatigue (967,537 reports)

Browse all side effects of Duspatalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fatigue:

Fatigue (4,027 drugs)

Browse all the conditions that are associated with Fatigue:

Fatigue (6,379 conditions)

Related publications that referenced our studies

Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on mebeverine hydrochloride (the active ingredients of Duspatalin) and Duspatalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.